ALNY : Alnylam Pharmaceuticals stock forecast, predictions, and share price target for 2021, 2022 (1 year) to 2025, 2026 (5 year) to 2030, and 2031 (10 year)

The 11 Wall Street analysts offering Alnylam Pharmaceuticals stock forecast in the last 6 months have average price target of $175.09 with a high forecast of $235.0 and a low forecast of $91.0. The average Alnylam Pharmaceuticals stock forecast represents a 27.09% increase from the last price of $137.77. From AI system, total return is 2053.81% from 1638 forecasts. For Alnylam Pharmaceuticals stock forecast 2021, 8 predictions are offered for each month of 2021 with average Alnylam Pharmaceuticals stock forecast of $111.32, a high forecast of $133.08, and a low forecast of $98.01. The average Alnylam Pharmaceuticals stock forecast 2021 represents a -19.2% decrease from the last price of $137.77. For Alnylam Pharmaceuticals stock forecast 2022, 12 predictions are offered for each month of 2022 with average Alnylam Pharmaceuticals stock forecast of $101.74, a high forecast of $103.46, and a low forecast of $100.13. The average Alnylam Pharmaceuticals stock forecast 2022 represents a -26.15% decrease from the last price of $137.77. For Alnylam Pharmaceuticals stock forecast 2025, 12 predictions are offered for each month of 2025 with average Alnylam Pharmaceuticals stock forecast of $107.95, a high forecast of $127.24, and a low forecast of $104.31. The average Alnylam Pharmaceuticals stock forecast 2025 represents a -21.64% decrease from the last price of $137.77. For Alnylam Pharmaceuticals stock forecast 2026 (5 year), 12 predictions are offered for each month of 2026 with average Alnylam Pharmaceuticals stock forecast of $128.69, a high forecast of $168.33, and a low forecast of $93.39. The average Alnylam Pharmaceuticals stock forecast 2026 represents a -6.59% decrease from the last price of $137.77. For Alnylam Pharmaceuticals stock forecast 2030, 12 predictions are offered for each month of 2030 with average Alnylam Pharmaceuticals stock forecast of $119.59, a high forecast of $166.75, and a low forecast of $96.01. The average Alnylam Pharmaceuticals stock forecast 2030 represents a -13.2% decrease from the last price of $137.77. For Alnylam Pharmaceuticals stock forecast 2031 (10 year), 4 predictions are offered for each month of 2031 with average Alnylam Pharmaceuticals stock forecast of $97.93, a high forecast of $99.66, and a low forecast of $96.31. The average Alnylam Pharmaceuticals stock forecast 2031 represents a -28.92% decrease from the last price of $137.77. Please, see more forecasts below.